Cleanroom Technology Market

Market Overview

The global cleanroom technology market size was valued at USD 3.62 billion in 2022. It is estimated to reach USD 5.57 billion by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). The technological advancements in cleanroom technology and the growing incidence of healthcare-acquired infections stimulate market growth.

A cleanroom, often known as a clean room, is a specially designed facility that maintains a very low concentration of airborne particles. It is well segregated, free of contaminants, and actively disinfected. Such rooms are frequently required in scientific research and industry production for all nanoscale activities, such as semiconductor manufacture. A cleanroom is designed to keep everything away from it, including dust, airborne organisms, vaporized particles, and whatever substance is handled inside.

A clean room can help keep materials from escaping. This is frequently the major goal in hazardous biology and nuclear work, as well as in pharmaceutics and virology. Cleanroom technology is frequently viewed overly narrowly because of the "room" element. Cleanroom technology encompasses significantly more than simply the cleanroom itself. This is why the phrase "contamination control" is more accurate. Cleanroom technology is constantly focused on the product to be protected. The best potential cleanliness solution can be found and implemented with process considerations and needs.

Market Dynamics

Global Cleanroom Technology Market Drivers

Technological Advancements in Cleanroom Technology

Cleanroom technological advances are projected to drive the market throughout the forecast period. Since World War II, the use of this technology in many industrial applications has grown. This technology was also used to produce airplanes, artillery, and tanks. At the same time, HEPA filters were discovered. Following the war, HEPA filter technology was employed in producing electronics and gyroscopes, among other things. Blowers and Crew improved contamination control in an operating room in 1960 by designing a unidirectional airflow system. The United States Air Force issued the first written paper on cleanroom requirements for industrial usage in 1961. The patent for the laminar flow room was awarded in 1962. The notion of laminar flow had been extended to industrial and manufacturing activities by 1970. Conventional cleanroom structures have high commercial availability of raw materials for building cleanrooms, lower installation costs compared to other choices, and fewer joints and seams to reduce biological contaminations.

Furthermore, one of the significant advantages of conventional cleanroom structures is the availability of fire-resistant cleanrooms and a wide choice of finishing goods, such as epoxy, fire-reinforced plastics, and vinyl sheeting with heat-molded steams. Modular cleanrooms, on the other hand, are replacing traditional cleanrooms due to their increased characteristics, such as uniqueness and flexibility. Modular cleanrooms have inherent versatility because they can be erected, disassembled, and relocated. They provide firms with cost-effective choices in the event of upgrades and changes in cleanliness regulations. When compared to standard modular cleanrooms, improved customized versions are available. Modular cleanrooms’ advantages include quick installation and reconfiguration as needed. This is likely to increase their popularity.

Growing Incidence of Healthcare-Acquired Infections

Healthcare-acquired infections (HAIs) have become more common recently. The CDC said that there were around 722,000 HAIs in the country. Similarly, the National Institute for Health and Care Excellence reported that roughly 300,000 patients in England contract HAI annually due to receiving care through the National Health Service. As a result, installing cleanrooms in hospitals has become increasingly necessary to combat the rising incidence of HAIs. In hospitals, cleanrooms are integrated into isolation sections, surgical suits, burn units, and, in some situations, corridors that frequently come into contact with biohazardous substances.

Global Cleanroom Technology Market Restraint

High Initial Installation Cost of Cleanrooms

One of the things that could hurt the market is the cleanrooms' hefty initial installation costs. For 4,400 square feet with class 10,000, upgrading to a cleanroom will cost roughly USD 0.5 million. The annual maintenance and monitoring cost is USD 8,000 for a cleanroom with comparable circumstances. Companies are pressured to produce high-quality goods that adhere to legal requirements while cutting prices. As a result, people are selecting economical alternatives.

Global Cleanroom Technology Market Opportunities

Technology Advancement

One of the key reasons propelling the market is technological progress in cleanroom technology. Benefits related to modular construction's advancement in cleanroom technology are among the key drivers predicted to propel the market. The market is expected to grow throughout the forecast period due to key players' constant efforts to upgrade their present technology or develop new products to remain competitive. However, several reasons are anticipated to impede the development of new drugs, including the capital-intensive structure of the market and the significant investments needed for the R&D of new updated goods. Premarket notification and approval are two of the many steps in the product approval process that are likely to take time and could cause a delay in the entire approval process.

Regional Analysis

Based on region, the global cleanroom technology market is bifurcated into North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant cleanroom technology market shareholder and is estimated to exhibit a CAGR of 6.4% over the forecast period. Due to significant pharmaceutical businesses, rising healthcare costs, growth in older adults, and a high illness load. The market for cleanroom technology in this area has been given various chances by the healthcare sector. The growth of various pharmaceutical, medical devices, biotechnology, and research organizations is driving the market for cleanroom technology. A new research facility has been constructed in the United States by Avantor, which provides life science enterprises with ultra-high purity components. Furthermore, because of the strict guidelines for product approvals, businesses are embracing cleanroom technologies on a big scale. Over the forecast period, the market is expected to be driven by the presence of key cleanroom suppliers.

Europe is anticipated to exhibit a CAGR of 4.4% over the forecast period. The growth of the pharmaceutical and healthcare industries, the rise in the geriatric population, the prevalence of chronic diseases, and high healthcare costs are the main factors driving the market for cleanroom technology in Europe. Among the few variables driving up demand for pharmaceuticals or nutraceuticals are favorable government efforts and increased disposable income in Europe. Positive market growth trends include increased access to cleanroom technology equipment and consumables and awareness of pure and high-quality products.

Asia-Pacific has emerged as one of the fastest-growing regions in the global market. High GDP growth is anticipated in this region, mostly driven by expansion in India, China, Singapore, Indonesia, and Australia, as well as improvements to the healthcare system. After North America and Europe, the Asia-Pacific region is thought to have the third-largest pharmaceutical sector. As a result, this region is seeing increased investment in healthcare industry advancements. The increase in generic medication production as a result of blockbuster drug patent expirations, the rise in the population of older people, and the burden of non-communicable diseases, including cancer, diabetes, and cardiovascular disease, are the main factors driving the expansion of the pharmaceutical sector in Asia and the Pacific. The market for cleanroom technology is expanding due to the considerations above.

In Latin America, the Production of over-the-counter medications, government initiatives to increase domestic investment, and increased production of generic drugs are some of the important elements influencing the growth of the pharmaceutical business. Additionally, a growing elderly population and the associated increase in illness burden fuel demand for medicines, which is likely to accelerate market expansion further.

In the Middle East and Africa, the area is important for the healthcare market. Because of the pharmaceutical industry's constant expansion, the cleanroom technology market in this region is still in its infancy. However, the pharmaceutical sector is anticipated to expand due to rising public and private investments, rising healthcare costs, and expanding public-private health collaborations. Therefore, the demand for cleanroom technology in MEA will rise as the pharmaceutical industry develops.

Segmental Analysis

The global cleanroom technology market is bifurcated into product type and end-use

Based on the product type, the global market is bifurcated equipment and consumables.

The consumables segment dominates the global market and is projected to exhibit a CAGR of 4.3% over the forecast period. Frequent usage of consumables, bulk purchases by manufacturing firms, a high requirement for preventing employee contamination, convenience, and different alternatives provided by the leading players are the main factors ascribed to this share. The segment with the fastest growth was equipment. Disposable and reusable items comprise cleanroom consumables, including face masks, gloves, beard covers, swabs, wipers, sticky mats, and adhesive tapes.

Cleanroom consumables are essential to maintaining the required level of cleanliness. They are employed to guarantee that contamination from shoes, hands, beards, and hair is avoided. Since operating employees are the main source of contamination, using consumables properly ensures safety in terms of contamination. As a result of rising consumption, it is anticipated that the demand for consumables will rise over the predicted period.

Based on end-use, the global market is bifurcated into the pharmaceutical industry, medical device industry, biotechnology industry, hospitals, and diagnostic centers. 

The pharmaceutical industry segment owns the highest cleanroom technology market share and is predicted to exhibit a CAGR of 4.1% over the forecast period. Depending on the regulatory approval needed, medical items and their manufacturing processes must adhere to regulatory standards, including FS 209 E, British Standards, and ISO. Low particulate air is necessary for pharmaceutical manufacture. 0.5 to 5 microns is the appropriate range for ISO classes 5 to 8.

Installing cleanroom technology tools like HVAC, air showers, and air diffusers assures the highest product quality with the least waste, maximizing yield and streamlining the manufacturing process. The pharmaceutical industry has boosted its use of cleanroom technology due to the considerations above, representing strong growth potential and likely driving market expansion over the forecast period.

Recent Developments

• July 2023- EM Microelectronic in Switzerland, a company in the electronic industry, has chosen CLESTRA Cleanroom to provide high-end cleanrooms. EM Microelectronic is a semiconductor company specializing in designing and manufacturing ultra-low power, low voltage integrated circuits for battery-powered and field-powered applications in consumer, automotive, and industrial markets.
• June 2023- Evotec announced the delivery of cleanroom PODs and the commencement of installation at its J.POD biologics manufacturing facility on Evotec's Campus Curie in Toulouse, France. G-CON, a global pioneer in off-site pre-fabricated cleanroom solutions, manufactured and shipped the cleanroom PODs, which will be erected over the following two weeks. G-CON previously supplied the cleanroom PODs for the first J.POD facility, which will open in August 2021 at Just - Evotec Biologics' campus in Redmond, WA (US).